Form 4 for RGEN REPLIGEN CORP
Accepted 2024-02-28 00:00:00 ET · period of report 2024-02-27 · accession 0000950170-24-022581 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-28 | 2024-02-27 | RGEN | DAWES KAREN A | Dir | S - Sale+OE | $193.35 | -1,000 | 87.4K | -1% | -$193.3K |
| D | 2024-02-28 | 2024-02-27 | RGEN | DAWES KAREN A | Dir | M - OptEx | $42.07 | +4,626 | 88.4K | +6% | +$194.6K |
| D | 2024-02-28 | 2024-02-27 | RGEN | DAWES KAREN A | Dir | M - OptEx | $0.00 | +4,626 | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-27 | S | D | 1,000 | $193.35 | 87,367 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-27 | M | A | 4,626 | $42.07 | 88,367 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-02-27 | M | A | 4,626 | $0.00 | 0 | D | $42.07 · — to 2028-05-16 | 4,626 Common Stock | (F1) This option is fully vested and exercisable. |